TITRE (EN) A Randomized Trial of Five-Fraction Partial Breast Irradiation
PROTOCOLE ID RAPID2
CLINICAL TRIAL.gov ID NCT05417516
TYPE(S) DE CANCER Sein
PHASE
TYPE D'ÉTUDE Clinique
INSTITUTION CENTRE UNIVERSITAIRE DE SANTE MCGILL
1001 boul. Décarie
VILLE Montréal
INVESTIGATEUR(RICE) PRINCIPAL(E) Tarek Hijal
COORDONATEUR(RICE) Marianna Perna
marianna.perna@muhc.mcgill.ca
514-934-1934 poste 43191
STATUT  Actif en recrutement
CRITÈRES D'ÉLIGIBILITÉ (EN)
  • Female with a new histological diagnosis of invasive carcinoma of the breast with no evidence of metastatic disease.(AJCC TNM Cancer Staging).
  • Treated by BCS with microscopically clear resection margins ≥ 1mm for invasive and non-invasive disease or no residual disease on re-excision.
  • Negative axillary node involvement as determined by either sentinel lymph node biopsy or axillary node dissection.
CRITÈRES D'EXCLUSION (EN)
  • Age less than 50 years.
  • Known to be BRCA 1 and/or BRCA 2 positive.
  • Tumour size >3cm in greatest diameter on pathological examination.
  • Lobular carcinoma only.
  • More than one primary tumour in different quadrants of the same breast (patients with multifocal breast cancer are eligible).
  • Synchronous or previous contralateral breast cancer (patients with contralateral DCIS or LCIS are eligible).
  • History of non-breast malignancy within the last 5 years other than treated non-melanoma skin cancer or treated in-situ carcinoma.
  • Known pregnancy or currently lactating.
  • Inability to localize tumour bed on CT planning (no evidence of surgical clips or seroma).
  • Inability to plan the patient for the experimental technique.